News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.
Researchers in the US and Europe are implementing pathogen sequencing surveillance programs to track infectious diseases within hospitals.
Researchers will use Adaptive's immune repertoire sequencing technology to look for a molecular signature of type 1 diabetes.
Natera plans to launch its clinical oncology and transplantation tests next year and is hopeful that guidelines endorsing NIPT for average-risk pregnancies are imminent.
The molecular diagnostics firm grew year-over-year testing volumes by 28 percent to 167,172.
The companies plan to study the current utility and understanding of NGS and precision medicine, and will provide educational programs in underserved areas.
